Northern Trust Corp Electro Core, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $15,075 - $19,127	16,210 Added 23.87%	84,131 $95,000
Q1 2021 May 12, 2021	BUY	$1.62 - $3.05 $18,676 - $35,163	11,529 Added 20.44%	67,921 $140,000
Q4 2020 Feb 11, 2021	BUY	$1.44 - $1.98 $13,805 - $18,982	9,587 Added 20.48%	56,392 $88,000
Q3 2020 Nov 16, 2020	SELL	$0.8 - $2.33 $1,671 - $4,867	-2,089 Reduced 4.27%	46,805 $81,000
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $85,255 - $146,639	-113,674 Reduced 69.92%	48,894 $40,000

Q1 2020 May 14, 2020	BUY	$0.33 - $1.62 $4,987 - $24,483	15,113 Added 10.25%	162,568 $154,000
Q4 2019 Feb 14, 2020	SELL	$1.23 - $2.67 $8,611 - $18,692	-7,001 Reduced 4.53%	147,455 $234,000
Q3 2019 Nov 13, 2019	BUY	$1.25 - $5.0 $43,771 - $175,085	35,017 Added 29.32%	154,456 $338,000
Q1 2019 May 13, 2019	BUY	$4.84 - $9.07 $256,723 - $481,090	53,042 Added 79.89%	119,439 $836,000
Q4 2018 Feb 12, 2019	BUY	$4.21 - $14.28 $19,888 - $67,458	4,724 Added 7.66%	66,397 $415,000
Q3 2018 Nov 14, 2018	BUY	$13.02 - $17.54 $802,982 - $1.08 Million	61,673 New	61,673 $864,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $445M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.